Showing results (661-670 of 1,570) with videos related to
Sort By:
Pageof 157
Clinical Science (London, England : 1979)|December 2, 2000
Elevated circulating leptin levels in arterial hypertension: relationship to arteriovenous overflow and extraction of leptinJ H Henriksen, J J Holst, S Moller, et al.Diabetes|January 8, 1998
Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion couplingJ Gromada, K Bokvist, W G Ding, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|February 24, 2007
Preserved GLP-1 effects in a diabetic patient with Cushing's diseaseR A Ritzel, N Kleine, J J Holst, et al.Regulatory Peptides|April 17, 2007
Glucagon-like peptide 1 (GLP-1) suppresses ghrelin levels in humans via increased insulin secretionDirk Hagemann, Jens J Holst, Arnica Gethmann, et al.JPEN. Journal of Parenteral and Enteral Nutrition|August 5, 2004
Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal pigletsAnne L Bartholome, David M Albin, David H Baker, et al.Biomarkers in Medicine|September 10, 2016
The biology of glucagon and the consequences of hyperglucagonemiaNicolai J Wewer Albrechtsen, Rune E Kuhre, Jens Pedersen, et al.The American Journal of Physiology|January 1, 1993
Regulation of secretion of pancreatic spasmolytic polypeptide from porcine pancreasT N Rasmussen, H Harling, L Thim, et al.Frontiers in Physiology|May 10, 2019
Glucagon Receptor Signaling and Lipid MetabolismKatrine D Galsgaard, Jens Pedersen, Filip K Knop, et al.Scandinavian Journal of Gastroenterology|May 1, 1989
Effect of low-dose exogenous secretin and somatostatin on pentagastrin-stimulated gastric acid secretion in manJ Olsen, P E Mortensen, O B Schaffalitzky de Muckadell, et al.Plos One|February 14, 2015
Targeting of non-dominant antigens as a vaccine strategy to broaden T-cell responses during chronic viral infectionPeter J Holst, Benjamin A H Jensen, Emeline Ragonnaud, et al.Pageof 157